Medtronic names new presidents for diabetes, surgical robotics, cardiac rhythm units

Medtronic (NYSE:MDT) is making leadership changes in its diabetes, surgical robotics and cardiac rhythm management operating units, the company said today.
Que Dallara joins the medtech giant as EVP and president of the diabetes business, Mike Marinaro is now the president of surgical robotics…

Source: www.massdevice.com – Read more